Khalili-Shirazi A, Gregson N, Webb H E
J Neurol Sci. 1986 Nov;76(1):91-103. doi: 10.1016/0022-510x(86)90144-9.
A monoclonal antibody (MAb) raised against central nervous system (CNS) myelin (212) and a MAb (308) raised against brain with Semliki Forest virus (SFV) were both found to react against the same CNS glycolipids. Both these MAbs were also found to react strongly with SFV and against certain brain glycolipid fractions in an immunosorbent assay (ELISA). This demonstrates the presence of common glycolipid antigens in the viral envelope and CNS myelin. MAb 212 had no SFV neutralising capacity and that of MAb 308 was not significant. However, MAb 212 inhibited the neutralisation of the virus by the MAbs (302, 307) specific to SFV proteins. The implications of these findings in relation to the viral induced CNS autoimmunity and persistence of virus in the CNS is discussed.
一种针对中枢神经系统(CNS)髓磷脂产生的单克隆抗体(MAb)(212)和一种针对感染Semliki森林病毒(SFV)的脑产生的单克隆抗体(308)均被发现可与相同的中枢神经系统糖脂发生反应。在免疫吸附测定(ELISA)中,还发现这两种单克隆抗体均与SFV以及某些脑糖脂组分发生强烈反应。这证明了病毒包膜和中枢神经系统髓磷脂中存在共同的糖脂抗原。单克隆抗体212没有SFV中和能力,单克隆抗体308的中和能力也不显著。然而,单克隆抗体212抑制了针对SFV蛋白的特异性单克隆抗体(302、307)对病毒的中和作用。讨论了这些发现与病毒诱导的中枢神经系统自身免疫以及病毒在中枢神经系统中的持续存在的关系。